by Cell Transplantation
Scientists have developed an advanced therapy medicinal product (ATMP) that aims to protect leukemia patients against tumor relapse and potentially fatal infection following haploidentical...
by Translational Oncology
Researchers believe development of chimeric antigen receptor (CAR) T cells targeting the C-X-C chemokine receptor type 4 (CXCR4) could play a role in treating both acute myeloid leukemia (AML) and...
by Transplantation and Cellular Therapy
Clinical study evidence indicates that toxic effects and infections associated with chimeric antigen receptor (CAR) T-cell therapy are leading contributors to non-relapse mortality (NRM) in...
by Transplantation and Cellular Therapy
Researchers report that outpatient (OP) administration of axicabtagene ciloleucel (axi-cel) is a viable alternative to inpatient (IP) delivery of the chimeric antigen receptor (CAR) T-cell therapy...
by Katie Harper
Across transplant centers in the United States, there is a lack of standard best practices regarding nutrition as it relates to hematopoietic stem cell transplantation.
A new...
by Zartash Gul
Allogeneic hematopoietic cell transplantation is a discipline defined by precision, planning, and—at times—fragility. Even when every variable appears controlled, the margin for error...